Follow the Q32 Bio Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €485.8m. The latest transaction was reported on 27 August 2026 (Cession). Among the most active insiders: Violette Shelia M.. All data is free.
28
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€429,087
13 ops.
Sell Volume
56Σ signal
Buys n/a€429,087 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,247 of 29,063 companies
68.0
score / 100
Value
44
Quality
92
FCF yld-7.6%
Earn yld6.7%
EV/EBITDA14.6x
ROE72%
Gross mgn·
Net mgn55%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
75 shares@ US$24.20100.0% of flowCommon StockSEC:0000950170-24-047018:0
25 of 28 declarations
Acerca de Q32 Bio Inc.
Q32 Bio Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para enfermedades autoinmunes e inflamatorias. Cotiza en NASDAQ bajo el ticker Q32.